vimarsana.com

Page 12 - புறக்கணிக்கப்பட்டது நோய்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Drug-resistant tuberculosis trial ends enrolment after positive initial data

Drug-resistant tuberculosis trial ends enrolment after positive initial data
msf.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msf.org Daily Mail and Mail on Sunday newspapers.

A little bit of everything : Campus research adds to COVID-19 knowledge

When the COVID-19 pandemic hit, UC Berkeley researchers from different areas of expertise rose in legions to respond to the crisis by studying the coronavirus and its impacts. Researchers across campus designed and executed new studies with unprecedented speed and urgency, and their work throughout the past year has made significant contributions to understanding the pandemic. While campus’s Innovative Genomics Institute began its diagnostic testing program, other researchers looked into mentalhealtheffects and increases in food insecurity, among other topics. Sarah Stanley, campus infectious diseases and vaccinology associate professor, said her lab one of three labs in the campus biosafety level 3 facility has been involved in “a little bit of everything.” Due to the risks involved with researching COVID-19, the live coronavirus must be studied in labs like Stanley’s, which have increased precautionary measures.

Federal Council concludes privileges and immunities agreement with GARDP

Federal Council concludes privileges and immunities agreement with GARDP Federal Department of Foreign Affairs Bern, 10.03.2021 - The Federal Council and the Global Antibiotic Research & Development Partnership (GARDP) signed an agreement on 10 March 2021 concerning the privileges and immunities of the organisation in Switzerland. The GARDP plays a major role in the fight against antibiotic resistance. The agreement was signed at a ceremony in Bern by Ambassador Corinne Cicéron Bühler, head of the Directorate of International Law (DIL) at the Federal Department of Foreign Affairs, on behalf of the Federal Council, and Mr Manica Balasegaram, executive director of the GARDP. The conclusion of the agreement was approved by the Federal Council at its meeting on 24 February 2021. The Host State Act is the legal basis for the agreement.

SA accuses states opposed to vaccine patent waiver of being of being pressurised by big pharma

(Photo by Karwai Tang/Getty Images) Those countries opposing the Covid-19 vaccine patent waiver are responsible for the majority of administered vaccines, while 130 other countries still haven t received a single dose, SA has claimed Mustaqeem de Gama, trade counsellor at the South African mission in Geneva, said the Trade-Related Aspects of Intellectual Property Rights waiver would offer a global solution to this.  De Gama accused World Trade Organisation members opposing the waiver of being under pressure from their pharmaceutical industry   Countries opposing the vaccine patent waiver at the World Trade Organisation are responsible for 60% of the globally administered Covid-19 vaccines, while 130 countries have not received a single dose, South Africa argued at the formal TRIPS Council meeting on Tuesday. 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.